372 related articles for article (PubMed ID: 19901119)
21. Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia.
Lopez-Lopez E; Ballesteros J; Piñan MA; Sanchez de Toledo J; Garcia de Andoin N; Garcia-Miguel P; Navajas A; Garcia-Orad A
Pharmacogenet Genomics; 2013 Feb; 23(2):53-61. PubMed ID: 23222202
[TBL] [Abstract][Full Text] [Related]
22. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
[TBL] [Abstract][Full Text] [Related]
23. Association between MTHFR microRNA binding site polymorphisms and methotrexate concentrations in Chinese pediatric patients with acute lymphoblastic leukemia.
Wang SM; Zeng WX; Wu WS; Sun LL; Yan D
J Gene Med; 2017 Nov; 19(11):353-359. PubMed ID: 28990296
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
Balis FM; Holcenberg JS; Poplack DG; Ge J; Sather HN; Murphy RF; Ames MM; Waskerwitz MJ; Tubergen DG; Zimm S; Gilchrist GS; Bleyer WA
Blood; 1998 Nov; 92(10):3569-77. PubMed ID: 9808549
[TBL] [Abstract][Full Text] [Related]
25. Endogenous Metabolites-Mediated Communication Between OAT1/OAT3 and OATP1B1 May Explain the Association Between SLCO1B1 SNPs and Methotrexate Toxicity.
Martinez D; Muhrez K; Woillard JB; Berthelot A; Gyan E; Choquet S; Andrès CR; Marquet P; Barin-Le Guellec C
Clin Pharmacol Ther; 2018 Oct; 104(4):687-698. PubMed ID: 29285751
[TBL] [Abstract][Full Text] [Related]
26. Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly.
Akao H; Polisecki E; Kajinami K; Trompet S; Robertson M; Ford I; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J; Packard C; Buckley BM; Schaefer EJ
Atherosclerosis; 2012 Feb; 220(2):413-7. PubMed ID: 22189199
[TBL] [Abstract][Full Text] [Related]
27. Study on Relationships of Tumor Status and Gene Polymorphism With Blood Concentration of MTX and Toxicities in 63 Pediatric Mature B Cell Lymphoma in Chinese Population.
Huang S; Jin L; Yang J; Duan LY; Zhang M; Zhou JC; Zhang HY
Technol Cancer Res Treat; 2021; 20():1533033821995288. PubMed ID: 33752528
[TBL] [Abstract][Full Text] [Related]
28. Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.
Petrykey K; Lippé S; Robaey P; Sultan S; Laniel J; Drouin S; Bertout L; Beaulieu P; St-Onge P; Boulet-Craig A; Rezgui A; Yasui Y; Sapkota Y; Krull KR; Hudson MM; Laverdière C; Sinnett D; Krajinovic M
PLoS One; 2019; 14(6):e0217314. PubMed ID: 31181069
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism in Organic Anion-Transporting Polypeptide Gene Related to Methotrexate Response in Rheumatoid Arthritis Treatment.
Takahashi K; Nakamura H; Watanabe A; Majima T; Koiwa M; Kamada T; Takai S
J Nippon Med Sch; 2019; 86(3):149-158. PubMed ID: 31292326
[TBL] [Abstract][Full Text] [Related]
30. Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma.
Shimasaki N; Mori T; Samejima H; Sato R; Shimada H; Yahagi N; Torii C; Yoshihara H; Tanigawara Y; Takahashi T; Kosaki K
J Pediatr Hematol Oncol; 2006 Feb; 28(2):64-8. PubMed ID: 16462575
[TBL] [Abstract][Full Text] [Related]
31. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.
Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V
Toxicol Sci; 2014 Nov; 142(1):196-209. PubMed ID: 25124723
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1).
van de Steeg E; van der Kruijssen CM; Wagenaar E; Burggraaff JE; Mesman E; Kenworthy KE; Schinkel AH
Drug Metab Dispos; 2009 Feb; 37(2):277-81. PubMed ID: 19022939
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia.
Gurieva OD; Savelyeva MI; Valiev TT; Sozaeva ZA; Kondratenko SN; Ilyin MV
Drug Metab Pers Ther; 2023 Dec; 38(4):349-357. PubMed ID: 38098143
[TBL] [Abstract][Full Text] [Related]
34.
Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E
Scand J Rheumatol; 2021 May; 50(3):213-217. PubMed ID: 33025831
[No Abstract] [Full Text] [Related]
35. MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia.
Iparraguirre L; Gutierrez-Camino A; Umerez M; Martin-Guerrero I; Astigarraga I; Navajas A; Sastre A; Garcia de Andoin N; Garcia-Orad A
Pharmacogenet Genomics; 2016 Nov; 26(11):517-525. PubMed ID: 27649261
[TBL] [Abstract][Full Text] [Related]
36. Association between SLCO1B1 polymorphism and methotrexate-induced hepatotoxicity: a systematic review and meta-analysis.
Han JM; Choi KH; Lee HH; Gwak HS
Anticancer Drugs; 2022 Jan; 33(1):75-79. PubMed ID: 34726639
[TBL] [Abstract][Full Text] [Related]
37. Germline genomic variants associated with childhood acute lymphoblastic leukemia.
Treviño LR; Yang W; French D; Hunger SP; Carroll WL; Devidas M; Willman C; Neale G; Downing J; Raimondi SC; Pui CH; Evans WE; Relling MV
Nat Genet; 2009 Sep; 41(9):1001-5. PubMed ID: 19684603
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.
Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ
Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298
[TBL] [Abstract][Full Text] [Related]
39. Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population.
Pasanen MK; Backman JT; Neuvonen PJ; Niemi M
Eur J Clin Pharmacol; 2006 Jun; 62(6):409-15. PubMed ID: 16758257
[TBL] [Abstract][Full Text] [Related]
40. Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure.
Endo S; Fukahori A; Tokuhiro S; Shinagawa A; Walker J; Yoshihara K; Ishizuka H; Ieiri I; Sugiyama Y
J Hum Genet; 2012 Aug; 57(8):531-44. PubMed ID: 22695893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]